Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 8.32M P/E - EPS this Y 44.30% Ern Qtrly Grth -
Income -7.46M Forward P/E -1.89 EPS next Y 43.80% 50D Avg Chg -5.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -27.00%
Dividend N/A Price/Book 0.70 EPS next 5Y - 52W High Chg -80.00%
Recommedations 2.00 Quick Ratio 14.18 Shares Outstanding 6.90M 52W Low Chg 66.00%
Insider Own 0.93% ROA -42.66% Shares Float 6.84M Beta 0.82
Inst Own 5.05% ROE -77.36% Shares Shorted/Prior 245.29K/212.46K Price 2.52
Gross Margin - Profit Margin - Avg. Volume 1,799,283 Target Price 4.50
Oper. Margin - Earnings Date Nov 11 Volume 47,193 Change -3.45%
About Hoth Therapeutics, Inc.

Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It develops HT-001, a topical formulation in Phase II clinical trial for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor inhibitor therapy; HT-KIT to treat mast-cell derived cancers and anaphylaxis; HT-TBI to treat traumatic brain injury and ischemic stroke; HT-ALZ for the treatment and/or prevention of Alzheimer's or other neuroinflammatory diseases; HT-004 for treatment of asthma and allergies using inhalational administration; and HT-003 for the treatment of acne and psoriasis, as well as inflammatory bowel diseases. The company is also developing BioLexa Platform, a proprietary, patented, drug compound platform in Phase I clinical trial for the treatment of eczema; and HT-005 for treating patients with lupus. The company has license agreements with the George Washington University; Isoprene Pharmaceuticals, Inc.; Virginia Commonwealth University; the North Carolina State University; Chelexa BioSciences, Inc. and the University of Cincinnati; Zylö Therapeutics, Inc.; and Voltron Therapeutics, Inc. It also has a research collaboration agreement with Weill Cornell Medicine to develop HT-003. Hoth Therapeutics, Inc. was incorporated in 2017 and is headquartered in New York, New York.

Hoth Therapeutics, Inc. News
10/29/24 Hoth Therapeutics Announces Update on Cancer Therapeutic HT-KIT Results Suggesting the Treatment Effectively Inhibited Tumor Growth in Preclinical Treatment Study
10/15/24 Hoth Therapeutics Awarded Key US Patent for Groundbreaking Alzheimer's Treatment and Prepares for Clinical Trials of HT-ALZ with Formulation Now Underway
09/17/24 Hoth Therapeutics Announces Promising Preclinical Results for Alzheimer's Drug HT-ALZ
09/06/24 Hoth Stock Up as Lead Drug Heals Skin Toxicities in Cancer Patient
09/05/24 Hoth Therapeutics Announces Expansion of Clinical Sites for HT-001 Phase 2a Trial
09/05/24 Hoth Therapeutics Announces Positive Data from First-of-its-Kind Human Patient Treatment of EGFRI-Associated Skin Toxicities with HT-001
08/16/24 Hoth and Aronnax partner for HT-KIT cancer therapy development
08/15/24 Hoth Therapeutics and Aronnax Inc. Enter Master Services Agreement For HT-KIT Cancer Therapeutic
07/24/24 Hoth Therapeutics Partners with LTS Therapy Systems to Accelerate Novel Alzheimer's Treatment
07/16/24 Hoth Therapeutics Expands Clinical Trial for Cancer Patients
06/10/24 Hoth Therapeutics Announces Joint Development Agreement with Wise Systems International SRL to Utilize Artificial Intelligence for Drug Discovery
05/01/24 Hoth Therapeutics to Attend EF Hutton Annual Global Conference, May 15, 2024
03/27/24 Hoth Therapeutics Announces Exercise of Warrants for $4.2 Million Gross Proceeds
03/27/24 Hoth Therapeutics' Wholly Owned Subsidiary Merveille.ai, Advances AI-Driven Discovery for Obesity Treatment
03/20/24 Hoth Therapeutics (HOTH) Up on Upbeat Alzheimer's Drug Data
03/19/24 Hoth Therapeutics Announces Positive Data In Completed Study of Alzheimer's Disease Pre-Clinical Treatment with HT-ALZ
02/29/24 Hoth Therapeutics Retains Venable LLP to Expand Its Patent Portfolio
02/26/24 Hoth Therapeutics Engages Altasciences to Perform Key Study for HT-KIT Cancer Fighting Therapeutic
02/13/24 Hoth Therapeutics to Attend BIO CEO and Investor Conference, February 26-27, 2024
01/18/24 Hoth Therapeutics Announces it Received FDA Approval to Expand HT-001 Clinical Trial to Treat Severely Ill Patients
HOTH Chatroom

User Image Stocksrunner Posted - 4 hours ago

$HOTH comeback strong!

User Image babakbb Posted - 4 hours ago

$HOTH Bounce off middle b-band on weekly chart for a crazy run?

User Image Travelling Posted - 4 hours ago

$sava buying to hold, my notes state strong buy with high PT of 116, low 44. I sold last time at 58 and 46. watching $kulr $pulm $crkn $hoth

User Image StocHunter Posted - 5 hours ago

$HOTH Entered let’s see how this goes. Off the recent news I’m looking at a reversal soon IMO. Reading the chats here. 🤦‍♂️ Stop blaming the company for panic sellers. They did their job announcing news to increase investor confidence. Not their fault people have none.

User Image Fast_Eddie_Felson Posted - 6 hours ago

$HOTH headed for r/s ya 🤡s Maybe don’t listen to dipshit pumpers like “ms tammy” and other 🤡s who don’t know shit about this scam

User Image TheFallGuy Posted - 6 hours ago

$HOTH -10% pm to 0 at open (: love this game. lets go

User Image ELDERBY Posted - 8 hours ago

$HOTH CDT gets patent news runs more than 100% but $hoth tanks more than regular price. Unbelievable

User Image StockRedBaron Posted - 8 hours ago

@DekmarTrades So did $HOTH -pump them!

User Image StockRedBaron Posted - 9 hours ago

$HOTH So $LQR buys BTC and it pops 30%, HOTH buys BTC and it goes down?? WTF ?

User Image TheFallGuy Posted - 10 hours ago

$HOTH opps

User Image babakbb Posted - 19 hours ago

$HOTH Top: Nice big green Heikin Ashi on daily chart. Bottom: Yesterday this had more volume and it barely moverd. Seems there's accumulation along the trend line. IMO this might've been brought down to their cost avg for a little shakeout. MMs hate running out of shares.

User Image Calvary316 Posted - 19 hours ago

$TNXP $HOTH $NCNC $ELAB

User Image Motorhhead Posted - 20 hours ago

$HOTH Easy money on the short side.

User Image EarlofLondon Posted - 21 hours ago

$HOTH wish I sold when I was in profit, Anyways This one missed by many ​folks need to look at The News of the day $KTTA' has posted Cancer treatment Phase1 had a good result in fact I reckon big Pharma would be knocking on their door​

User Image Notaecire Posted - 21 hours ago

$HOTH this stock is garbage.

User Image forza_juve Posted - 22 hours ago

$HOTH So….i guess the patent that was officially awarded on Nov 19/24 was the same one as Oct 15/24? Why no news release today to state they officially received it and an update on operations? Or was it the same patent?? I still don’t get it. Almost 10mil shares traded which is almost double the outstanding shares (which means all the float changed hands almost twice). Yet the share price was even. Now it’s red in after hours. So why all the buying after hours yesterday that drove the price to $1.23? Was it ignorant people that thought there are two patents? Or just more manipulation??

User Image Motorhhead Posted - 23 hours ago

@Z_interceptor Good, that hunk of junk $HOTH hit .82 today. Hopefully it'll hit .42 soon, LOL.

User Image Peak_Big Posted - 23 hours ago

$HOTH 3 days of 9 million or more volume this month...you'd think bulls would get sick of buying the dip and try buying higher. 🤔 oh well. Maybe in their next trade.

User Image Peak_Big Posted - 1 day ago

$HOTH someone's buying single shares at 0.89 to show investors how to buy higher. It just takes one person to buy 5000 shares one share at a time at the ask regardless of price but noones willing to risk it for a profit so take a loss "bulls"

User Image Peak_Big Posted - 1 day ago

$HOTH people fighting for lower prices instead of buying higher will only lead to lower stock prices.

User Image Sithvsjedi Posted - 1 day ago

$HOTH 9 million shares traded 6 mill float and 1%change manipulation bullshit

User Image Fringe Posted - 1 day ago

$HOTH too fucking easy to short this trash. How do you bulls not see this?

User Image Peak_Big Posted - 1 day ago

$HOTH keep fighting for lower priced shares guys! Waaaay better than fighting for higher prices and creating fomo bulls!

User Image BearishAlgo Posted - 1 day ago

$HOTH Just reflecting (sharing my thought process) here on this stock. My algorithm produced an INTRADAY shortsell alert yesterday (the alert is the white circle), and I was concerned about the news, powerful one in my opinion which is it was granted a patent for treating Alzheimer's disease (not just in talks, or rumors)(could be a reason to invest for the long term, lots of due diligence needed here to confirm). My point here is that if we see excellent news/catalyst, that doesn't always indicate a sure thing direction whatsoever, and that's why I'm laser focused on price action itself, it's the ultimate judge of all.

User Image Fringe Posted - 1 day ago

$HOTH bye bye. Back to .70’s after hours. Panic selling about to begin.

User Image babakbb Posted - 1 day ago

$HOTH And a quick look at weekly. Showing higher lows and a wedge pattern. Support 0.84. Don't be surprised if this staff running tmrw

User Image Pain_without_Mercy Posted - 1 day ago

$HOTH and again shorted to death. Zero shares left to borrow.

User Image babakbb Posted - 1 day ago

$HOTH Daily chart.

User Image Joeejet Posted - 1 day ago

$HOTH peak big must be getting nervous

User Image Peak_Big Posted - 1 day ago

$HOTH if you are a Hoth long, do you also enjoy receiving golden showers?

Analyst Ratings
HC Wainwright & Co. Buy Aug 16, 24
HC Wainwright & Co. Buy Jul 26, 24
HC Wainwright & Co. Buy Jul 22, 24
HC Wainwright & Co. Buy Apr 5, 24
EF Hutton Buy Apr 2, 24
HC Wainwright & Co. Buy Feb 5, 24
EF Hutton Buy Sep 14, 23
Benchmark Speculative Buy Jun 20, 23
EF Hutton Buy Apr 27, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Knie Robb CEO and President CEO and President Sep 19 Buy 0.39 10,000 3,900 828,259 09/20/22
Knie Robb CEO and President CEO and President Sep 16 Buy 0.40 10,000 4,000 818,259 09/19/22